ClinicalTrials.Veeva

Menu

Treatment Outcomes of Retroperitoneal Sarcoma

T

Taichung Veterans General Hospital

Status

Active, not recruiting

Conditions

Retroperitoneal Sarcoma

Treatments

Procedure: tumor wide excision

Study type

Observational

Funder types

Other

Identifiers

NCT06612671
CE23365A

Details and patient eligibility

About

Investigators tried condult a retrospective study to analysis the prognostic factors and oncological outcome analysis of Retroperitoneal Sarcoma treated in our high volume medical center.

Full description

Retroperitoneal Sarcoma (RPS) which is a rare disease which incidence is 1.79/100,000. The treatment is difficult to due to it anatomy position which often invade to multiple organs and cause the complete surgical resection to be very complex and difficult. It was known to sacrifice one side kidney will improve the resection rate. To this days, successful surgical resection was still the gold standard that provide most benefit in overall survival. To reach that goal, pre-operative radiotherapy was applied to RPS which intended to achieve similar effect in rectal cancer for the down staging effect and improved the respectability but with limited benefit. Herein, investigators conducted this study to find the best way to achieve successful surgical resection and prognostic factor analysis.

Enrollment

150 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • the patient who have retroperitoneal maliganacy and receive complete tumor excision in our hospital

Exclusion criteria

  • the patient did not receive complete tumor excision in our hospital
  • the pathological report yielded not malignancy tumor

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems